Sunridge Builds off its Successful Meetings in the Dominican Republic

FOUNTAIN HILLS, Ariz., April 14 /PRNewswire-FirstCall/ -- Sunridge International (OTC Bulletin Board: SNDZ) announced today, that with the completion of two very successful meetings in the Dominican Republic last month, it has been given the opportunity to present its patented Pneumatic Trabeculoplasty treatment (PNT) at the upcoming Sociedad Dominicana de Oftalmologia conference that will be held in Punta Cana, Dominican Republic, June 3-6th.

Last month's seminars, which were given to over 40 local doctors in the Dominican Republic (DR), were a success.  Dr. Bores worked with the local doctors and Luis Tiant (star pitcher for the New York Yankees and Boston Red Sox) to demonstrate and teach the benefits of PNT.  Luis Tiant was in attendance to bring media exposure to glaucoma, which is at an epidemic rate throughout the Caribbean islands.  Luis Tiant through his Luis Tiant Foundation and the Scientific Social Solutions Charitable Foundation (S3) of Boston, have partnered with Sunridge International in a medical relief program to provide PNT treatments at no cost to patients suffering from glaucoma in Cuba.

Sunridge International's CEO, G. Richard Smith, states that, "Its local distributor in the DR is following up at the current time with the meeting attendees and is taking orders for equipment and rings to allow them to start treating patients in their local practices."  Mr. Smith goes on to say that "While these sales are important to the company, we are very excited about making a presentation at the upcoming conference in June.  Attendance for this conference is expected to draw doctors from every Caribbean Island.  It's venues like this that allow us to spread the success we are having in one area to another.  We expect that this meeting will act as a catalyst for us to install equipment and roll out marketing efforts all throughout the Caribbean."

Glaucoma is the second leading cause of blindness, affecting over 70 million people worldwide. PNT has been proven (through studies completed over the last 10 yrs) to be a safe, effective, non-invasive and a cost effective alternative for treatment for glaucoma and ocular hypertension. The 2-minute treatment has been developed, patented, and distributed by Sunridge International, wholly owned subsidiary, Ophthalmic International (www.oi-pnt.com).

For full details of PNT and its application, we invite you to visit Sunridge International's website at www.sunridgeint.com.

SOURCE Sunridge International